Alnylam Expands Leadership Team with Multiple Experienced Biotech Leaders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 223.94 +4.05 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $219.89 | 52 Week High | $109.10 | |||
| Open | $221.01 | 52 Week Low | $31.38 | |||
| Day High | $229.18 | P/E | N/A | |||
| Day Low | $217.18 | EPS | $-1.45 | |||
| Volume | 1,356,363 | |||||
